NBIX vs POOL · P/E 45, rev $2.36B vs P/E 18, rev $5.31B
Neurocrine Biosciences Inc (NBIX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the NBIX and POOL stock pages for the full models.
Not investment advice.